Antilipemic agents encompass a class of pharmaceutical compounds designed to treat patients with elevated blood lipids, including cholesterol, triglycerides, and phospholipids, often associated with dyslipidemia.… Read more
Antilipemic agents encompass a class of pharmaceutical compounds designed to treat patients with elevated blood lipids, including cholesterol, triglycerides, and phospholipids, often associated with dyslipidemia. This category includes active pharmaceutical ingredients, their pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled standards, such as those derived from nicotinic acid derivatives like Acipimox. Pharmaceutical laboratories utilize these high-quality reference standards for rigorous analytical testing, including impurity profiling and quantitative method validation. By employing stable isotope-labelled compounds, researchers can improve the accuracy of mass spectrometry-based assays, ensuring precise quality control during the development and production of lipid-lowering medications. These essential tools support the reliable identification and quantification of impurities, helping to maintain compliance with regulatory standards for pharmaceutical formulations.